Low-dose aspirin, coxibs, and other NSAIDS: a clinical mosaic emerges.

Low-dose aspirin, coxibs, and other NSAIDS: a clinical mosaic emerges.

Aspirin has been a commercial drug for over a century, although for most of this history, an understanding of its mechanism of action, as an inhibitor of cyclooxygenase (COX) activity and thus of prostanoid synthesis, was lacking. Over the past fifty years, a large number of other nonsteroidal antii...

Полное описание

Библиографические подробности
Главные авторы:	Patrono, C, Baigent, C
Формат:	Journal article
Язык:	English
Опубликовано:	2009

Схожие документы

Coxibs and traditional NSAIDs for pain relief - Authors' reply.
по: Bhala, N, и др.
Опубликовано: (2014)

Coxibs and traditional NSAIDs for pain relief - Authors' reply.
по: Bhala, N, и др.
Опубликовано: (2014)

Review: NSAIDs increase GI and CV events; coxibs increase mortality
по: Baigent, C
Опубликовано: (2013)

Coxibs, traditional NSAIDs and cardiovascular safety post-PRECISION: What we thought we knew then and what we think we know now
по: Patrono, C, и др.
Опубликовано: (2017)

Low-dose aspirin for the prevention of atherothrombosis.
по: Patrono, C, и др.
Опубликовано: (2005)

Drug therapy - Low-dose aspirin for the prevention of atherothrombosis
по: Patrono, C, и др.
Опубликовано: (2005)

ASA, NSAIDs, Coxibs and Colorectal Cancer Prevention — How Far Have We Come?
по: Martin Fishman
Опубликовано: (2004-01-01)

Antiplatelet therapy: aspirin for asymptomatic atherosclerosis?
по: Patrono, C, и др.
Опубликовано: (2010)

Role of aspirin in primary prevention of cardiovascular disease
по: Patrono, C, и др.
Опубликовано: (2019)

Nonsteroidal anti-inflammatory drugs (NSAIDs), cyxlooxygenase-2 selective inhibitors (coxibs) and gastrointestinal harm: review of clinical trials and clinical practice
по: Moore, R, и др.
Опубликовано: (2006)

Selective cyclooxygenase 2 inhibitors, aspirin, and cardiovascular disease: a reappraisal.
по: Baigent, C, и др.
Опубликовано: (2003)

Nonsteroidal anti-inflammatory drugs (NSAIDs), cyxlooxygenase-2 selective inhibitors (coxibs) and gastrointestinal harm: review of clinical trials and clinical practice
по: Phillips Ceri J, и др.
Опубликовано: (2006-10-01)

Pharmacoutilization of anti-inflammatory and gastroprotective drugs in patients with osteoarthritis: comparison between COXIBs and conventional NSAIDs by using administrative records
по: Luca Degli Esposti, и др.
Опубликовано: (2006-01-01)

Gastric and renal effects of COX-2 selective and non-selective NSAIDs in rats receiving low-dose aspirin therapy
по: Marcella Goetz MORO, и др.

Aspirin Actions in Treatment of NSAID-Exacerbated Respiratory Disease
по: Esha Sehanobish, и др.
Опубликовано: (2021-06-01)

Results of the PRECISION study: Could an answer be given to the question of how safe coxibs versus traditional NSAIDs are in treating patients at high risk for cardiovascular events?
по: E. V. Dovgan
Опубликовано: (2017-09-01)

Cardiac toxicity of coxibs: mechanisms of development and their prevention
по: O O Yakovleva, и др.
Опубликовано: (2018-11-01)

Opinion - Coxibs: can this class of drugs survive?
по: Reza Tabrizchi
Опубликовано: (2005-04-01)

COX-2 SPECIFIC INHIBITORS (COXIBS) CRISIS
по: Abbas Ali Mansour
Опубликовано: (2003-12-01)

What is safer for the gastrointestinal-tract: Coxibs or meloxicam?
по: A. M. Satybaldyev, и др.
Опубликовано: (2017-03-01)

Pathogenesis of NSAID-induced reactions in aspirin-exacerbated respiratory disease
по: Tanya M. Laidlaw
Опубликовано: (2018-09-01)

NSAIDs, Mitochondria and Calcium Signaling: Special Focus on Aspirin/Salicylates
по: Yoshihiro Suzuki, и др.
Опубликовано: (2010-05-01)

Rofecoxib-Induced Hepatotoxicity: A Forgotten Complication of the Coxibs
по: Brian Yan, и др.
Опубликовано: (2006-01-01)

The adverse effects of different doses of aspirin: a systematic overview of randomised trials and observational studies
по: Sudlow, G, и др.
Опубликовано: (2000)

Low-dose aspirin for migraine prophylaxis.
по: Buring, J, и др.
Опубликовано: (1990)

COX-2 inhibitors and the heart: are all coxibs the same?
по: Sooriakumaran, P
Опубликовано: (2006)

Determination of the prevalence of clinical signs of Aspirin and NSAID poisoning in patients referring to Ahvaz Razi Hospital
по: Maryam Shirani, и др.
Опубликовано: (2022-09-01)

Benefit of heparin plus aspirin vs aspirin alone in unstable angina.
по: Collins, R, и др.
Опубликовано: (1996)

Aspirin for everyone older than 50? Against.
по: Baigent, C
Опубликовано: (2005)

Monoclonal antibody or aspirin desensitization in NSAID-exacerbated respiratory disease (N-ERD)?
по: Dorien Van Broeck, и др.
Опубликовано: (2023-04-01)

Faecal blood loss: Systematic review and analysis of randomised trials with aspirin and NSAIDs
по: Moore, A, и др.
Опубликовано: (2007)

LOW-DOSE ASPIRIN IN PREGNANCY AND EARLY-CHILDHOOD DEVELOPMENT - FOLLOW-UP OF THE COLLABORATIVE LOW-DOSE ASPIRIN STUDY IN PREGNANCY
по: Farrell, B, и др.
Опубликовано: (1995)

Aspirin for disease prevention: public policy or personal choice?
по: Baigent, C
Опубликовано: (2016)

Variability in aspirin efficacy: all in the genes?
по: Baigent, C, и др.
Опубликовано: (2019)

Efficacy and safety of simvastatin and safety of low-dose aspirin among patients with chronic kidney disease: Final results of the first UK-Heart and Renal Protection (UK-HARP-1) study.
по: Baigent, C, и др.
Опубликовано: (2002)

Farmacoeconomia dei COXIB nella patologia osteoarticolare: revisione della letteratura
по: Pierluigi Russo, и др.
Опубликовано: (2003-05-01)

Aspirin, platelet inhibition and cancer prevention
по: Paola Patrignani, и др.
Опубликовано: (2018-11-01)

Aspirin at 120: Retiring, recombining, or repurposing?
по: Carlo Patrono, и др.
Опубликовано: (2021-05-01)

3437 Associations of aspirin, non-aspirin NSAIDs, statins, and metformin with risk of biliary cancer: A Swedish population-based cohort study
по: Lorena Marcano Bonilla, и др.
Опубликовано: (2019-03-01)

Quality of Life in NSAIDs-Exacerbated Respiratory Disease on or off Intranasal Lysine Aspirin Therapy
по: Alfonso Luca Pendolino, и др.
Опубликовано: (2024-01-01)